New to Meducation?
Sign up
Already signed up? Log In

Category

2
1
12

Should Surgery be Considered for Very Limited Small Cell Lung Cancer? (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Howard (Jack) West, medical oncologist, President &amp; CEO of GRACE, reviews the debate about whether surgery should have a role in managing early small cell lung cancer (SCLC).</span></p>  
Howard (Jack) West, MD
over 8 years ago
3
1
23

Q&A with Dr. Suresh Ramalingam on Individualizing First Line Therapy for Advanced NSCLC (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, discusses questions about individualizing therapy choices for patients with advanced NSCLC.</span></p>  
Howard (Jack) West, MD
over 8 years ago
4
1
24

Q&A with Dr. Suresh Ramalingam on Individualizing First Line Therapy for Advanced NSCLC (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, discusses questions about individualizing therapy choices for patients with advanced NSCLC.</span></p>  
Howard (Jack) West, MD
over 8 years ago
5
1
22

Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.</span></p>  
Howard (Jack) West, MD
over 8 years ago
6
1
32

Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.</span></p>  
Howard (Jack) West, MD
over 8 years ago
9
1
26

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Isolated Brain Metastasis (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of man with an isolated brain metastasis being considered for curative therapy.</span></p>  
Howard (Jack) West, MD
over 8 years ago
10
1
28

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Isolated Brain Metastasis (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of man with an isolated brain metastasis being considered for curative therapy.</span></p>  
Howard (Jack) West, MD
over 8 years ago
1
1
23

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Malignant Pleural Mesothelioma (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of a relatively fit man with malignant pleural mesothelioma.</span></p>  
Howard (Jack) West, MD
over 8 years ago
2
1
14

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Malignant Pleural Mesothelioma (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of a relatively fit man with malignant pleural mesothelioma.</span></p>  
Howard (Jack) West, MD
over 8 years ago
3
2
22

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
over 8 years ago
4
1
13

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
over 8 years ago
5
1
20

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Indolent BornchioloAlveolar Carcinoma (BAC) (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.</span></p>  
Howard (Jack) West, MD
over 8 years ago
6
1
34

Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Indolent Bronchioloalveolar Carcinoma (BAC) (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.</span></p>  
Howard (Jack) West, MD
over 8 years ago
7
1
12

Interview with Dr. Kristin Manning, Part 2: Challenges in Cancer Imaging (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.</span></p>  
Howard (Jack) West, MD
over 8 years ago
8
1
9

Interview with Dr. Kristin Manning, Part 2: Challenges in Cancer Imaging (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses difficulties in characterizing ambiguous imaging findings and the potential risks associated with radiation from medical imaging.</span></p>  
Howard (Jack) West, MD
over 8 years ago
9
1
24

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
over 8 years ago
10
1
25

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
over 8 years ago
11
1
41

IInterview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
over 8 years ago
12
1
18

Interview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
over 8 years ago
13
1
10

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (audio)

<p><span style="font-family: Times; font-size: medium;"> </span></p <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;"><span style="font-family: Times; font-size: medium; white-space: normal;"> </span></span></span></p <span style="font-family: arial, sans, sans-serif; font-size: small;" <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></span></p </div </span <p>&nbsp;</p </div <p>&nbsp;</p>  
Howard (Jack) West, MD
over 8 years ago